- 专利标题： Gender-specific markers for diagnosing prognosis and determining treatment strategy for renal cancer patients
-
申请号： US15779108申请日： 2017-09-27
-
公开(公告)号： US11243206B2公开(公告)日： 2022-02-08
- 发明人: Yeong Jin Choi
- 申请人： THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- 申请人地址： KR Seoul
- 专利权人： THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- 当前专利权人： THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- 当前专利权人地址： KR Seoul
- 代理机构： Vorys. Sater, Seymour and Pease LLP
- 代理商 Mih Suhn Koh
- 优先权： KR10-2016-0124785 20160928,KR10-2017-0123572 20170925
- 国际申请： PCT/KR2017/010741 WO 20170927
- 国际公布： WO2018/062862 WO 20180405
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68 ; G01N33/574 ; C12Q1/6886
摘要：
The present invention relates to markers for diagnosing the difference in effects of renal cancer treatment or the prognosis of renal cancer patients, according to the gender of renal cancer patients. The survival rate and recurrence rate of renal cancer of a particular gender respectively relate to the mutation of genes, of the present invention, in renal cancer patients, and thus the mutated genes of the present invention can be used as markers in predicting, on the basis of gender, the difference in effects of renal cancer treatment or the prognosis of renal cancer patients.
公开/授权文献
信息查询
